Skip to search formSkip to main contentSkip to account menu

rontalizumab

Known as: Immunoglobulin G1, anti-(human interferons alpha type); humanized mouse monoclonal rhuMAB IFNalpha gamma1 heavy chain (des-CH3(sup 107)K, CH1(sup 97)R>K-IGHG1*03) (220-218')-disulfide with humanized mouse monoclonal rhuMAB IFNalpha kappa light chain, dimer (226-226'':229-229'')-bisdisulfide, RhuMAb IFNalpha 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Background Type I interferon (IFN) pathway activation has long been demonstrated in patients with systemic lupus erythematosus… 
Review
2016
Review
2016
There is abundant evidence that B-lymphocytes play a major role in the development of lupus (reviewed in [1]). It thus seemed… 
Review
2016
Review
2016
Background Over the last decades evidence of an activated type I interferon (IFN) system in the pathogenesis of different… 
2009
2009
The currently recommended treatment for patients infected with hepatitis C virus (HCV) is pegilated interferon α (IFN α) plus… 
2001
2001
Transgenic mice expressing IL-3 and IFN-alpha under the regulatory control of the GFAP gene promoter (GFAP-IL3 and GFAP-IFNalpha… 
2000
2000
Interferon (IFN)-alpha is the main IFN produced in response to viral infection. Low levels of IFNalpha can be detected in nasal… 
2000
2000
We conducted a randomized controlled trial to assess the efficacy of twice-a-day administration of natural interferon beta… 
2000
2000
OBJECTIVE To study the effects of monotherapy with leucocyte interferon-alpha (IFNalpha) versus IFNalpha + ribavirin in patients…